Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production begins; US says 2 billion doses ‘ready to go’Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month ................. With the search for a Covid-19 vaccine becoming nothing less than the holy grail for scientists, enormous attention and funding have been focused on developing and mass-producing an injection. The rapid spread of SARS-nCov-2 has led experts to declare that it would continue to spread if a vaccine cannot be found. .......... British pharma giant AstraZeneca, which is developing a vaccine in partnership with Oxford University, said it was “on track” to roll out up to two billion doses in September. Meanwhile, US also said that it had already produced two million vaccine doses that are “ready to go” if they “check out for safety”. ........... Addressing the summit, Prime Minister Modi said, “Our support to Gavi is not only financial. India’s huge demand brings down the global price of vaccines.” ........ British pharma giant AstraZeneca has started to mass-produce its experimental AZD1222 vaccine, being developed by Oxford University, and plans to roll out up to two billion doses of a coronavirus vaccine in September. ........... “So far we’re still on track… we are starting to manufacture this vaccine right now, and we have to have it ready to be used by the time we have the results,” AstraZeneca chief executive Pascal Soriot told BBC radio. “Our present assumption is that we will have the data by the end of the summer, by August, so in September we should know whether we have an effective vaccine or not” ............. AstraZeneca announced this week it had struck agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, and the Serum Institute of India to double production capacity of the vaccine to two billion doses. The partnership with the Indian institute — one of the world’s largest vaccine manufacturers — will help supply it to a large number of low- and middle-income countries .............. Oxford University began initial trials of its Covid-19 vaccine with hundreds of volunteers in April, and is now expanding them to 10,000 participants. .............. The Cambridge-based firm has signed deals to produce 400 million doses for the US and 100 million for the UK if it is successful in human trials.
No comments:
Post a Comment